Indaptus Therapeutics GAAP EPS of -$2.98
Source: SeekingAlpha
2025-11-12 09:58:30 ET
More on Indaptus Therapeutics
- Seeking Alpha’s Quant Rating on Indaptus Therapeutics
- Historical earnings data for Indaptus Therapeutics
- Financial information for Indaptus Therapeutics
Read the full article on Seeking Alpha
For further details see:
Indaptus Therapeutics GAAP EPS of -$2.98
Indaptus Therapeutics Inc.
NASDAQ: INDP
INDP Trading
-13.46% G/L:
$3.60 Last:
2,223,265 Volume:
$3.22 Open:
INDP Latest News
May 15, 2026 07:00:00 am
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
December 29, 2025 07:00:00 am
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
November 17, 2025 08:00:00 am
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
November 12, 2025 08:30:00 am
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
INDP Stock Data
$4,058,606
690,636
2.23%
3
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
